Sproutly Announces JV with Moosehead

Today Sproutly Canada and Moosehead Breweries (OCC Holdings) announced they have entered into a definitive agreement to form an exclusive joint venture to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using Sproutly’s proprietary, naturally produced water soluble cannabinoids known as ‘Infuz2O’.

With the anticipated legalization of edibles in Canada later this year, Moosehead has made the strategic decision to enter the cannabis beverage market. As one of the oldest brands in Canada and a leader in the beer category, we believe we are uniquely positioned to be a leader in the cannabis beverage category.

Andrew Oland, Chief Executive Officer of Moosehead.

From the NR, we highlighted a few key points:

  • Mooshead’s proven track record as operators
    • Over 152 years of brewing experience.
    • More than 140 million cans/bottles of beer sold annually.
  • Sproutly’s beverage tech – Infuz2O
    • The JV beverages can deliver the cannabis effect as early as 5 minutes and last up to 90 minutes.
    • Capability to produce a clear cannabis beverage.
  • Positioned Entering Cannabis Beverages Upon Legalization
    • Moosehead’s established operational infrastructure will allow the Joint Venture to fast track its go-to-market strategy.
    • Sproutly’s cultivation facility and processing license will advance the formulation work that has been completed to date as well as production scale up.
Source: Sproutly Investor Deck

“The JV’s ability to leverage Moosehead’s rich history of building adult-beverage brands, and its established R&D and operational infrastructure, will enable the JV to bring great tasting cannabis beverages to Canadian consumers. The Infuz20 technology delivers a natural cannabis beverage experience, with an onset and offset time similar to traditional flower cannabis, without the need for chemical modification. We believe this will be a game changer for the sector.”

Matthew Oland, CEO of the Incoming JV

Terms of the Joint Venture (JV)

The JV will be structured as a standalone company with its own board of directors and management team. Sproutly and Moosehead will each hold a 50% interest in the JV and have the right to nominate 3 directors. Moosehead shall appoint the Chief Executive Officer and Sproutly shall appoint the Chairperson of the board of directors of the JV.

Sproutly will provide Infuz20 exclusively to the JV in Canada for the purpose of producing cannabis beverages (excluding hemp) for a period of 5 years, such Exclusivity Period being subject to a potential extension based on the Joint Venture reaching certain revenue targets.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Selkirk Copper Strikes New Lens Beneath Old Pit, Launches 50,000 Metre Phase 2 Program

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Related News

DEA Administrator Reportedly Didn’t Sign Cannabis Rescheduling Order, But Is It Necessary?

Recent developments regarding the signing of a marijuana rescheduling order have sparked debate and speculation...

Wednesday, May 8, 2024, 12:32:39 PM

Loblaws Wants In Cannabis, Urges Ford Government to Revise Retail Regulation

With a bid to enter the expanding cannabis market in Ontario, grocery giant Loblaw (TSX:...

Wednesday, January 17, 2024, 02:03:33 PM

Canada Wants Its Excise Taxes On Cannabis

Canada’s tax collection agency is taking action to retrieve outstanding excise duty payments from licensed...

Thursday, February 29, 2024, 11:41:00 AM

BRIEFING: Tinley Ships First Batches of Liquor ‘Inspired’ Cannabis Beverages For Those Looking to Make ‘Mocktails’

Today Tinley Beverage Company announced they shipped their first batches of the Company’s liquor-inspired Tinley™...

Tuesday, April 23, 2019, 10:19:52 AM

Will the US Only Legalize Medical Cannabis First?

In a recent testimony before the House of Representatives Committee on Oversight and Accountability, FDA...

Saturday, April 20, 2024, 12:14:00 PM